Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
treatment-resistant tumors
Research
Fighting drug-resistant cancer by blocking an escape route
A new Science Signaling study pointed to a DNA damage response pathway that helps cancer cells escape destructions by chemo and radiotherapy.
Angus Liu
Jan 5, 2022 8:35am
Treating resistant prostate cancer via tumor-suppressing RNA
Nov 5, 2021 10:00am
Tyra banks $173M to bring cancer resistance programs into clinic
Sep 15, 2021 10:20am
Tyra Biosciences wants to bank $100M for an IPO
Aug 23, 2021 7:05am
Nuvalent newest biotech to file for $100M IPO to fund 2 trials
Jul 7, 2021 2:56pm
Nuvalent bags $135M to trial next-gen kinase inhibitors
May 11, 2021 7:00am
